Literature DB >> 6154948

Interferon-treated cells release vesicular stomatitis virus particles lacking glycoprotein spikes: correlation with biochemical data.

R K Maheshwari, A E Demsey, S B Mohanty, R M Friedman.   

Abstract

Earlier we reported a reduction to 1/30th-1/100th of the original number of infectious particles in the infectious vesicular stomatitis virus (VSV) released from L cells treated with 10 or 30 reference units of interferon per ml. However, in these cultures virus particle production, as measured by VSV particle-associated viral RNA, virus nucleocapsid protein, and viral transcriptase, was inhibited by less than 10%. Data reported in this paper show that there was a significant reduction in glycoprotein and membrane protein of VSV particles released from interferon-treated cells. Evidence supporting the deficiency of glycoprotein in VSV released from interferon-treated cells was derived from electron microscopic studies. Under conditions where glycoprotein spikes or projections were clearly detectable on the surface of VSV released from cells not treated with interferon, very few spikes were observed on VSV released from interferon-treated cells. These results suggested that interferon-treated cells produced VSV particles with low infectivity and that this low infectivity may be related to the reduced amount of glycoprotein and membrane protein incorporated into such particles.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6154948      PMCID: PMC348698          DOI: 10.1073/pnas.77.4.2284

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Absence of surface projections of some noninfectious forms of RSV.

Authors:  C de Giuli; S Kawai; S Dales; H Hanafusa
Journal:  Virology       Date:  1975-07       Impact factor: 3.616

2.  Influence of interferon on virus-particle synthesis in oncornavirus-carrier lines. II. Evidence for a direct effect on particle release.

Authors:  A Billiau; V G Edy; H Sobis; P de Somer
Journal:  Int J Cancer       Date:  1974-09-15       Impact factor: 7.396

3.  A type of chick embryo cell that fails to support formation of infectious RSV.

Authors:  T Hanafusa; T Miyamoto; H Hanafusa
Journal:  Virology       Date:  1970-01       Impact factor: 3.616

4.  Inhibition of murine leukemia virus production in chronically infected AKR cells: a novel effect of interferon.

Authors:  R M Friedman; J M Ramseur
Journal:  Proc Natl Acad Sci U S A       Date:  1974-09       Impact factor: 11.205

5.  Purification of mouse interferon by affinity chromatography on anti-interferon globulin-sepharose.

Authors:  C A Ogburn; K Berg; K Paucker
Journal:  J Immunol       Date:  1973-10       Impact factor: 5.422

6.  A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.

Authors:  W M Bonner; R A Laskey
Journal:  Eur J Biochem       Date:  1974-07-01

7.  Enhancement by interferon of the expression of surface antigens on murine leukemia L 1210 cells.

Authors:  P Lindahl; P Leary; I Gresser
Journal:  Proc Natl Acad Sci U S A       Date:  1973-10       Impact factor: 11.205

8.  Structural proteins of vesicular stomatitis viruses.

Authors:  R R Wagner; T A Schnaitman; R M Snyder
Journal:  J Virol       Date:  1969-04       Impact factor: 5.103

9.  Interferon action: inhibition of vesicular stomatitis virus RNA synthesis induced by virion-bound polymerase.

Authors:  P I Marcus; D L Engelhardt; J M Hunt; M J Sekellick
Journal:  Science       Date:  1971-11-05       Impact factor: 47.728

10.  Proteins of vesicular stomatitis virus and of phenotypically mixed vesicular stomatitis virus-simian virus 5 virions.

Authors:  J J McSharry; R W Compans; P W Choppin
Journal:  J Virol       Date:  1971-11       Impact factor: 5.103

View more
  11 in total

1.  A confocal and electron microscopic comparison of interferon beta-induced changes in vesicular stomatitis virus infection of neuroblastoma and nonneuronal cells.

Authors:  Paul M D'Agostino; Carol Shoshkes Reiss
Journal:  DNA Cell Biol       Date:  2010-03       Impact factor: 3.311

2.  Effect of cloned human interferon-alpha 2a on bovine parainfluenza-3 virus. Brief report.

Authors:  P Panigrahi; S B Mohanty; R K Maheshwari; R M Friedman
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

3.  Defective transport of hemagglutinin-neuraminidase glycoprotein of bovine parainfluenza-3 virus in interferon treated cell.

Authors:  P Panigrahi; S B Mohanty
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

4.  Adenovirus early region 1A modulation of interferon antiviral activity.

Authors:  K P Anderson; E H Fennie
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

5.  Inhibition of vesicular stomatitis viral mRNA synthesis by interferons.

Authors:  L S Belkowski; G C Sen
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

6.  IFN-beta-induced alteration of VSV protein phosphorylation in neuronal cells.

Authors:  Paul M D'agostino; Jessica J Amenta; Carol Shoshkes Reiss
Journal:  Viral Immunol       Date:  2009-12       Impact factor: 2.257

7.  Use of Brefeldin A to localize block in intracellular transport of vesicular stomatitis virus G protein on interferon-treated cells.

Authors:  K Polakova; G Russ
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

8.  Loss of infectivity by progeny virus from alpha interferon-treated human immunodeficiency virus type 1-infected T cells is associated with defective assembly of envelope gp120.

Authors:  B D Hansen; P L Nara; R K Maheshwari; G S Sidhu; J G Bernbaum; D Hoekzema; M S Meltzer; H E Gendelman
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

9.  Effect of interferon on the replication of mink cell focus-inducing virus in murine cells: synthesis, processing, assembly, and release of viral proteins.

Authors:  J A Bilello; N A Wivel; P M Pitha
Journal:  J Virol       Date:  1982-07       Impact factor: 5.103

10.  The nitric oxide pathway provides innate antiviral protection in conjunction with the type I interferon pathway in fibroblasts.

Authors:  Devangi R Mehta; Ali A Ashkar; Karen L Mossman
Journal:  PLoS One       Date:  2012-02-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.